1DUNN G P, BRUCE A T, IKEDA H, et al. Cancer immunoediting: from immunosurveillance to tumor escape [J]. Nat Imrnunol, 2002, 3(11) : 991 -998.
2DUNN G P, OLD L J, SCHREIBER R D, et al. The three ES of cancer immunoediting [ J ]. Ann Rev Immunol, 2004, 22 ( 2 ) : 329 - 360.
3SMYTH M J, THIA K Y, STREET S E, et al. Differential tumor surveillance by natural killer (NK) NKT cells [ J ]. J Exp Med, 2000, 191(4) : 661 -668.
4GEROSA F, BALDANI GUERRA B, NISII C, et al. Reciprocal activating interaction between natural killer cells and dendritic cells [J]. J Exp Med, 2002, 195(3) : 327 -333.
5STREET S E, TRAPANI J A, MACGREGOR D, et al. Suppression of lymphoma and epithelial malignancies effected by interferon-γ[J]. J Exp Med, 2002, 196(1) : 129-134.
6SMYTH M J. Type Ⅰ interferon and cancer immunoediting[ J]. Nat Imrnunol, 2005, 6 (7) : 646 - 648.
7RSSELL J H, LEY T J. Lymphocyte mediated cytotoxicity [ J ]. Annu Rev Immunol, 2002, 20(2) : 323 -370.
8STREET S E, CRETNEY E, SMYTH M J. Perforin and interferon -γactivities independently control tumor initiation, growth, and metastasis[J]. Blood, 2001, 97(1): 192-197.
9SINGH R, PATERSON Y. lmmunoediting sculpts tumor epitopes during immunotherapy [ J ]. Cancer Res, 2007, 67 ( 5 ) : 1 887 - 1 892.
10MACKIE R M, REID R, JUNOR B. Fatal melanoma transferred in a donated kidney 16 years after melanoma surgery[J]. N Engl J Med, 2003, 348(6) : 567 -568.
二级参考文献53
1Burke B, Giannoudis A, Corke KP, et al. Hypoxia-induced gene expression in human macrophages: implications for ischemic tissues and hypoxia-regulated gene therapy [ J]. Am J Pathol, 2003, 163 (4) : 1233-1243.
2Burke B, Tang N, Corke KP, et al. Expression of HIF-1alpha by human macrophages: implications for the use of macrophages in hypoxia-regulated cancer gene therapy [ J]. J Pathol, 2002, 196 (2) : 204-212.
3Chai CY, Chen WT, Hung WC, et al. Hypoxia-inducible factor-1 {alpha} expression correlates with focal macrophage infiltration, angiogenesis and unfavorable prognosis in urothelial carcinoma [J]. J Clin Pathol, 2007, Oct 1 [ Epub ahead of print]
4Shi J, Ross CR, Leto TL, et al. PR-39, a proline-rich antibacterial peptide that inhibits phagocyte NADPH oxidase activity by binding to Sre homology 3 domains of p47^phox[J]. Proc Natl Acad Sci USA, 1996, 93(12) : 6014-6018.
5Albina JE, Henry WL Jr, Mastrofrancesco B, et al. Macrophage activation by culture in an anoxic environment [ J ]. J Immunol, 1995, 155(9) : 4391-4396.
6Gordon S. Alternative activation of macrophages [ J ]. Nat Rev Immunol, 2003, 3 ( 1 ) : 23-35.
7Martinez FO, Sica A, Mantovani A, et al. Macrophage activation and polarization [J]. Front Biosci, 2008, 13: 453-461.
8Stout RD, Jiang C, Matta B, et al. Macrophages sequentially change their functional phenotype in response to changes in microenvironmental influences [J]. J Immunol, 2005, 175 ( 1 ) : 342- 349.
9Duluc D, Delneste Y, Tan F, et al. Tumor-associated leukemia inhibitory factor and IL-6 skew monocyte differentiation into tumorassociated macrephage-like cells [ J ]. Blood, 2007, 110 ( 13 ) : 4319-4330.
10Montuenga LM, Pio R. Tumour-associated macrophages in non-small cell lung cancer: the role of interleukin-10 [J]. Eur Respir J, 2007, 30(4) : 608-610.
7Linn Y C, Hui K M. Cytokine-induced killer cells: NK-like T cells with cytotolytic specificity against leukemia [ J ]. Leuk Lymphoma, 2003, 44(9) : 1457 -1462.
8Dunn G P, Bruce A T, Ikeda H, et al. Cancer immunoediting: from immunosurveillance to tumor escape [ J ].Nat Immunol, 2002, 3 ( 11 ) : 991 - 998.
9Jiang J, Xu N, Wu C, et al. Treatment of advanced gastric cancer by chemotherapy combined with autologous cytokine-induced killer cells [J]. Anticancer Res, 2006, 26(3B) : 2237-2242.
10Kim R, Emi M, Tanabe K. Cancer immunoediting from immune surveillance to immune escape[ J]. Immunology, 2007, 121 ( 1 ) : 1 - 14.
